SME PAISA Pulse — 13 August 2026

MSME credit: banks, NBFCs and TReDS face a fresh push

For India’s ₹5–500 crore businesses, access to capital is becoming less about simply finding a lender and more about finding the right funding structure.

The latest policy discussion around MSME financing points towards three important areas: stronger bank-NBFC co-lending, wider use of TReDS for receivables financing, and better financial information to help lenders assess businesses more effectively.

For founders and CFOs, the message is straightforward: the way you structure your funding can be as important as the amount you borrow.

Banking & Credit

A stronger push for bank-NBFC co-lending

[Parliamentary Finance Committee — reported 12 August 2026] A parliamentary panel has called for wider structured co-lending between banks and NBFCs to improve MSME access to formal credit and help bring down borrowing costs.

The recommendation comes against an estimated $530 billion formal MSME credit gap, highlighting the continuing difference between the amount of credit businesses need and the amount available through formal channels.

Banks generally have access to lower-cost funding, while NBFCs can bring specialised underwriting capabilities, sector knowledge and greater flexibility in reaching businesses that may not fit conventional bank lending models.

A stronger co-lending ecosystem could therefore combine the strengths of both.

→ What this means for you: If bank funding is restrictive but your business has a strong operating track record, expect greater attention to blended bank-NBFC credit models as lenders look for ways to serve the underserved middle market.

For a growing business, this also means it can be useful to look beyond a single lender. Depending on the requirement, businesses may need to evaluate bank finance, NBFC funding, structured debt and working-capital solutions together rather than treating them as separate options.

TReDS could become more important for working capital

[Parliamentary Finance Committee — reported 12 August 2026] The committee has also called for a stronger TReDS ecosystem to address the liquidity pressure created by delayed receivables.

This matters because a profitable business can still experience a cash-flow squeeze when customers take longer to pay.

For example, a company may have ₹10 crore worth of invoices outstanding while simultaneously needing to pay salaries, suppliers, GST, utilities and other operating expenses. On paper, the company has revenue and receivables. In reality, the cash may not yet be available.

That gap between sales and actual cash collection is where working-capital pressure builds.

TReDS and invoice financing can potentially help businesses convert eligible receivables into liquidity instead of waiting for the entire payment cycle to run its course.

→ What this means for you: Businesses with sizeable B2B receivables should treat invoice financing as part of their planned working-capital strategy, not simply as an emergency source of funds.

The bigger strategic point is that businesses should monitor their receivable ageing, debtor concentration and collection cycle as closely as they monitor sales.

Higher sales do not automatically mean stronger liquidity if receivables are growing faster than cash collections.

Better financial data can influence funding outcomes

[Parliamentary Finance Committee — Committee Report] The panel noted that NBFC-MSME credit has expanded sharply while structural gaps in formal lending remain. It also linked stronger co-lending structures with the potential to reduce the higher risk-adjusted cost faced by smaller borrowers.

This makes the quality of a company's financial information increasingly important.

For lenders, the story of a business is not limited to its turnover. They may also look at cash flows, banking behaviour, receivables, repayment history, profitability, GST data and overall financial discipline.

A business that has strong numbers but poorly organised financial information can face unnecessary friction during a funding process.

On the other hand, a company with a clear financial trail can make it easier for lenders to understand its actual credit profile.

→ What this means for you: A stronger financial file—clean GST and banking data, disciplined receivables, transparent cash flows and organised financial statements—can become increasingly important when lenders assess your business across multiple funding channels.

Before approaching lenders for a major facility, management should therefore review whether its financial data tells a consistent story.

Why This Matters Beyond Getting a Loan

The emerging funding environment is changing the way MSMEs should think about borrowing.

The old approach was often straightforward:

Need money → approach bank → apply for loan.

For a growing ₹5–500 crore business, the better approach is increasingly:

Business requirement → identify funding gap → select the right instrument → structure the facility → approach the right lenders.

A company financing machinery, for example, may have a different requirement from a company dealing with long receivable cycles.

Similarly, an exporter may require a combination of working capital and trade-related facilities, while a fast-growing manufacturer may need a larger mix of term debt and working-capital limits.

This is why credit strategy matters.

The objective should not simply be to maximise sanctioned debt. It should be to build a funding structure that supports growth without creating unnecessary pressure on cash flows.

Export & Sector Watch

Pharma exports continue to show momentum

[Pharma Export Market Update — 12 August 2026] India’s pharmaceutical exports reached $8.10 billion in Q1 FY27, up from $7.58 billion a year earlier.

North America, Europe, Africa and Latin America accounted for nearly three-quarters of shipments, highlighting the continued importance of international markets for India's pharmaceutical sector.

For MSMEs and mid-sized businesses operating across pharma manufacturing, healthcare supplies and related value chains, export growth can create opportunities—but scaling production for international demand also brings additional financial requirements.

Businesses may need more working capital to purchase raw materials, maintain inventory, fulfil larger orders and manage longer international payment cycles.

At the same time, export-oriented businesses need to remain prepared for quality, documentation and regulatory requirements in their target markets.

→ What this means for you: Pharma and healthcare suppliers in the MSME and mid-market segment may see stronger order opportunities, but scaling exports will require adequate working capital, disciplined cash-flow management and continued investment in quality and regulatory readiness.

For businesses already operating in export markets, this is also a reminder to align financing with the actual order cycle rather than waiting for cash-flow pressure to emerge.

What Business Owners Should Watch Next

The most important takeaway from this week's funding conversation is not simply that more credit may become available.

It is that the architecture of MSME credit is evolving.

Three areas deserve attention:

1. Co-lending

More collaboration between banks and NBFCs could create additional funding routes for businesses that do not fit neatly into one lender's traditional model.

2. Receivables financing

Businesses with large B2B receivables should assess whether invoice financing can improve liquidity and reduce dependence on conventional working-capital borrowing.

3. Financial readiness

Companies seeking larger facilities should keep their banking, GST, receivables, profitability and cash-flow information organised and consistent.

For founders, the practical lesson is simple:

Don't wait until you need funding urgently to understand your funding options.

A well-planned credit strategy can give management more flexibility when expansion opportunities, large orders or temporary cash-flow gaps arise.

This Week's Deadline Watch

No fresh MSME-specific compliance deadline surfaced in the 11–13 August window.

Bottom Line

India's MSME funding conversation is gradually moving beyond “more loans” towards better credit architecture.

Co-lending can potentially broaden access to formal credit. TReDS and receivables financing can help address working-capital pressure. And stronger financial data can help lenders understand the actual risk and performance of a business.

For a ₹5–500 crore company, this makes financing strategy as important as financing availability.

The right question is not always:

“How much funding can we get?”

It is often:

“What is the right funding structure for our business, our cash cycle and our next stage of growth?”

If these developments affect your borrowing capacity, working-capital cycle or expansion plans, talk to SME PAISA about debt syndication, credit consulting or working-capital advisory.

— Team SME PAISA

Subject: MSME credit: banks, NBFCs and TReDS face a fresh push

For today’s edition, we’re deliberately leaving yesterday’s MSME Amendment Bill story out. The fresh signal is on how India can close the MSME funding gap—with a parliamentary panel pushing stronger bank-NBFC co-lending and wider use of TReDS.

Banking & Credit

[Parliamentary Finance Committee — reported 12 August 2026] A parliamentary panel has called for wider structured co-lending between banks and NBFCs to improve MSME access to formal credit and bring down the cost of borrowing. The recommendation comes against an estimated $530 billion formal MSME credit gap.

→ What this means for you: If bank funding is tight but your business has a strong operating track record, expect more focus on blended bank-NBFC credit models as lenders look for ways to serve the underserved middle market.
[Parliamentary Finance Committee — reported 12 August 2026] The committee has also called for a stronger TReDS ecosystem to tackle liquidity pressure created by delayed receivables.

→ What this means for you: Businesses with sizeable B2B receivables should treat invoice financing as part of their working-capital strategy—not just as an emergency funding option.
[Parliamentary Finance Committee — Committee Report] The panel noted that NBFC-MSME credit expanded sharply, while structural gaps in formal lending remain. It specifically linked better co-lending structures with the potential to reduce the higher risk-adjusted cost currently faced by smaller borrowers.

→ What this means for you: A stronger financial file—clean GST/banking data, disciplined receivables and transparent cash flows—can become increasingly important when lenders assess your business across multiple funding channels.

Export & Sector Watch

[Pharma Export Market Update — 12 August 2026] India’s pharmaceutical exports reached $8.10 billion in Q1 FY27, up from $7.58 billion a year earlier, with exports to North America, Europe, Africa and Latin America accounting for nearly three-quarters of shipments.

→ What this means for you: Pharma and healthcare suppliers in the MSME/mid-market segment may see stronger order opportunities, but scaling exports will require adequate working capital and continued investment in quality and regulatory readiness.

This Week's Deadline Watch

No fresh MSME-specific compliance deadline surfaced in the 11–13 August window.

Bottom line: The funding conversation is moving beyond “more loans” toward better credit architecture—co-lending, receivables financing and stronger lender data. For a ₹5–500cr business, that makes financing strategy as important as financing availability.

If this affects your borrowing capacity, working-capital cycle or expansion plans, talk to SME PAISA about debt syndication, credit consulting or working-capital advisory.

— Team SME PAISA

Search This Blog

Sme Paisa